Thursday 22 October, 2020

Professor Jeanne Tie from the Walter Eliza Hall Institute for Medical Research (WEHI) is pioneering the use of circulating tumour DNA (ctDNA) as an indicator for risk of cancer recurrence and treatment response in colorectal and pancreatic cancer. To validate the clinical use of ctDNA, Professor Tie leads several multi-site phase II/III Clinical trials across 5 Melbourne hospitals recruiting over 200 patients.

Since 2014, Professor Tie's team have engaged the services of the VCB to ensure co-ordinated and time-sensitive specimen collection, processing and dispatch across multiple hospitals.

The Victorian Cancer Biobank through the Cancer Council Victoria as Lead Agency is supported by the Victorian Government through the Victorian Cancer Agency, a business unit of the Department of Health.

RAP Victorian Cancer Biobank would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.

Jump to page top

Consortium members

Cancer Council Victoria Austin Health Eastern Health Monash Health Peter Mac Royal Melbourne Hospital

Supported by